Losartan potassium NDC 68788-4091

NDC codes

FDA NDC Directory

Product NDC (as listed)68788-4091Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68788-4091Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68788-4091-3	68788409103	30 TABLET, FILM COATED in 1 BOTTLE (68788-4091-3)Marketed from Mar 17, 2026
68788-4091-9	68788409109	90 TABLET, FILM COATED in 1 BOTTLE (68788-4091-9)Marketed from Mar 17, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Losartan potassium
Generic name (nonproprietary): losartan potassium
Active ingredients: Losartan potassium — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Preferred Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217396
Marketing start: Mar 17, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 68788-4091_05818573-0b40-4731-a9d1-152c708905bfSPL ID 05818573-0b40-4731-a9d1-152c708905bfSPL set ID 05818573-0b40-4731-a9d1-152c708905bfRxCUI 979485UNII 3ST302B24A
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788409103 followed by a unit qualifier and the quantity

Package 68788-4091-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 17, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Losartan potassium tablet is an angiotensin II receptor blocker (ARB) indicated for: • Treatment of hypertension, to lower blood pressure in adults and children greater than 6 years old. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) • Reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy. There is evidence that this benefit does not apply to Black patients. ( 1.2 ) • Treatment of diabetic nephropathy with an elevated serum creatinine and proteinuria in patients with type 2 diabetes and a history of hypertension. ( 1.3 ) 1.1 Hypertension Losartan potassium tab…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217396

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217396
Product	Strength	Form · route	Labeler	Product NDC
Losartan potassium	Losartan potassium 25 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-141
Losartan potassium	Losartan potassium 50 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-142
Losartan potassium	Losartan potassium 100 mg/1	Tablet, Film coatedOral	Novadoz Pharmaceuticals LLC	72205-143
Losartan potassium	Losartan potassium 25 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-1470